Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 351 - 400 out of 97,368

Document Document Title
WO/2017/037629A1
Provided are improved microorganisms for the biosynthesis of pamamycins. Also provided are methods for the production of pamamycins using these microorganisms.  
WO/2017/037692A1
The present invention provides a process for production of fucoxanthin and/or polysaccharides from microalgae and the use of purified fucoxanthin thereof in pharmaceutical, cosmetic, nutraceutical and food compositions.  
WO/2017/035856A1
A Wautersiella enshiensis YLX-1 strain and application thereof, wherein the strain is deposited in China Center for Type Culture Collection (Wuhan) with the accession number being CCTCC No: M 2013671. The strain has the characteristics o...  
WO/2017/040719A1
The present invention provides recombinant bacterial cells comprising at least one heterologous gene encoding at least one oxalate catabolism enzyme. In another aspect, the recombinant bacterial cells further comprise at least one hetero...  
WO/2017/038993A1
The objective of the present invention is to provide a eukaryotic microalga which has been genetically manipulated so that more of the anabolites produced by photosynthesis are directed into triglyceride (triacylglycerol, TAG) synthesis....  
WO/2017/037241A1
The present application relates to the field of yeast, and specifically to the identification of yeast alleles that are involved in maximal alcohol accumulation and/or in tolerance to high alcohol levels. Preferably, said alcohol is etha...  
WO/2017/039361A1
The present invention relates to a Bacillus amyloliquefaciens CJ14-6 strain which is a strain isolated from traditional meju, a soybean koji preparation method using the same, and soybean koji prepared by the preparation method. The soyb...  
WO/2017/036294A1
Disclosed are Kluyveromyces marxianus, especially a type of Kluyveromyces marxianus with a deposit number of CGMCC No.10621; a use of the Kluyveromyces marxianus, the use comprising constructing a recombinant protein expression system an...  
WO/2017/036140A1
An A-group Neisseria meningitidis cultivation method comprises the following steps: (1) preparing purified strains of a working seed lot; (2) opening the strains of the working seed lot, inoculating same into a semi-synthetic culture med...  
WO/2017/039106A1
The present invention relates to a novel strain Methylomonas sp. DH-1 and a use thereof and, more specifically, to a strain Methylomonas sp. DH-1, deposited as Accession Number KCTC13004BP, synthesizing methanol from methane, to a compos...  
WO/2017/040273A2
Compositions and methods for treating or preventing plant disease are provided. Such compositions and methods comprise a bacterial strain that control one or more pathogens that cause plant disease or improve at least one agronomic trait...  
WO/2017/033464A1
A method for producing an objective substance such as phytosphingosine and sphinganine using yeast is provided. An objective substance is produced by cultivating yeast having an ability to produce the objective substance and modified so ...  
WO/2017/035270A1
Provided herein are recombinant host cells having an active 3-Hydroxypropionic Acid (3-HP) pathway wherein the host cells comprise a heterologous polynucleotide encoding an aminotransferase of E.C. 2.6.1.19 and wherein the aminotransfera...  
WO/2017/034388A2
Present invention discloses a method of production of Lignocellulolytic enzymes such as laccase, CMCase, xylanase and amylase under solid state fermentation (SSF) from white- rot basidiomycete's fungi Pycnporus sanguineus (GanoBF2). The ...  
WO/2017/034984A1
The presently disclosed subject matter provides methods for inhibiting the growth and/or survival of bacteria from the Borrelia genus and for treating Lyme disease. These methods include agents that inhibit the glutathione/γ-glutamyl pa...  
WO/2017/033652A1
The present invention addresses the problem of providing a novel short-chain polyhydroxyalkanoate (PHA) having free hydroxy groups and a method for producing the same. Provided are a PHA that comprises, each as a monomer unit, a dihydrox...  
WO/2017/031838A1
Disclosed is a method for producing L-ornithine by whole-cell biotransformation using recombinant Bacillus subtilis, wherein the method comprises constructing Bacillus subtilis 168 engineering bacteria which express arginase originated f...  
WO/2017/031985A1
Provided is an application of Butyribacterintestini in the treatment and prevention of obesity and obesity-related diseases. Also provided is a composition for the treatment and prevention of obesity and obesity-related diseases.  
WO/2017/034388A3
Present invention discloses a method of production of Lignocellulolytic enzymes such as laccase, CMCase, xylanase and amylase under solid state fermentation (SSF) from white- rot basidiomycete's fungi Pycnporus sanguineus (GanoBF2). The ...  
WO/2017/034011A1
The present invention pertains to a proliferation agent for increasing, or causing the proliferation of, beneficial intestinal bacteria (primarily, bifidobacteria and/or lactobacilli), the proliferation agent being characterized by conta...  
WO/2017/035191A1
The present invention is a method of enriching at least one bacterial species from a target bacterial system, including: culturing the target bacterial ecosystem in a culture media in a single-stage chemostat under the following conditio...  
WO/2017/033925A1
Provided is a novel butyric acid-producing bacterium that belongs to the Clostridium leptum subgroup, and, in a butyric acid-free culture medium, produces butyric acid but does not produce formic acid.  
WO/2017/034387A3
The embodiments of the present invention relate to a method of producing lignocellulolytic enzymes using a species of white rot fungi by solid stale fermentation (SSF) is provided. The method comprises obtaining artificially modified fun...  
WO/2017/034387A2
The embodiments of the present invention relate to a method of producing lignocellulolytic enzymes using a species of white rot fungi by solid stale fermentation (SSF) is provided. The method comprises obtaining artificially modified fun...  
WO/2017/034827A1
A method for increasing the concentration of metal carbonates in a heavy metal contaminated geomaterial utilizing indigenous ureolytic microorganisms. The method may be used for bioremediation of heavy metal contaminated geomaterials.  
WO/2017/032909A1
Disclosed are mutant strains of Staphylococcus aureus with multiple inactivated TCS systems. The invention relates to mutant strains of S. aureus deprived of all non-essential two-component signal systems (TCSs) and even the essential Wa...  
WO/2017/034460A1
The present invention relates to a composition for use in the treatment and/or prevention of a gastrointestinal condition, comprising at least one Lactobacillus strain, wherein the Lactobacillus strain is chosen from the group consisting...  
WO/2017/031839A1
Provided are an L-asparaginase mutant with improved enzyme activity and a construction method thereof, wherein the mutant is constructed on the basis of the amino acid sequence as shown in the SEQ ID NO.2, in which glycine at position 10...  
WO/2017/035101A1
The present specification discloses plant agent compositions, articles of manufacture, containers or kits comprising such compositions, and methods and uses to control a causal agent of a plant disease or increasing plant growth and/or f...  
WO/2017/035188A1
The present invention provides a method, wherein the method treats a subject having a dysbiosis, the method comprising: determining a first metabolic profile of the gut microbiome of a subject having a dysbiosis; changing the first metab...  
WO/2017/035141A3
The present invention provides microorganisms capable of converting acetyl-coA into crotyl alcohol as well as fermentation methods for producing crotyl alcohol, either alone, or in combination with acetone and/or isopropanol. The microor...  
WO/2017/034942A1
The present invention relates to the production of chemical species in bacterial host cells. Particularly, the present invention provides for the production of chemical species in Escherichia coli (E. coli) host cells that functionally e...  
WO/2017/034699A1
The present invention is directed to a method and kit for inactivation of acid -fast bacteria. In some embodiments, the method may include: transferring a sample from a liquid culture containing acid-fast bacteria to a first tube, wherei...  
WO/2017/033188A1
Methods of producing algal oil and algal biofuel are provided. Accordingly there is provided a method of producing oil, the method comprising infecting Emiliania huxleyi microalgae with a Coccolithovirus Eh V201; and extracting the oil f...  
WO/2017/032739A1
The present invention relates to methods and pharmaceutical compositions for preventing or treating inflammatory bowel diseases.  
WO/2017/033965A1
Provided is a method for producing an aromatic compound, e.g., salicylic acid, and a derivative thereof with high productivity using a microorganism. Provided are: a method for producing a microorganism having a modified sugar metabolic ...  
WO/2017/029833A1
Provided is a method for site-specific insertion of a foreign DNA into an animal cell genome, said method comprising: (1) a step for constructing a donor plasmid in which 100-300 bp DNAs having a sequence homologous to an insertion site ...  
WO/2017/030503A1
The present invention relates to the field of fermentation biotechnology, more particularly to methods for the fermentative production of massoia lactone by Aureobasidium species.  
WO/2017/031277A1
Provided herein are methods for identifying and obtaining environmental isolates of microorganisms that maintain viability following seed treatment components or seed treatment processes and storage.  
WO/2017/030172A1
A neutral monoclonal antibody useful for effective antibody therapy against Ebola virus is needed. The present invention provides a monoclonal antibody or antigen-binding fragment thereof that is capable of recognizing the GP internal me...  
WO/2017/028040A1
The present invention provides a mycobacterium tuberculosis antigen for differentiating active tuberculosis with latent tuberculosis infection and applications thereof. Specifically, the present invention provides an immunogenic composit...  
WO/2017/030156A1
The present invention pertains to: a monoclonal antibody or a fragment thereof that includes at least one lysine derivative in the constant region of the human IgG antibody; a modified antibody or a fragment thereof in which the lysine d...  
WO/2017/029823A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, a filter is used to separate a biological culture solution including micro-nanobubbles into a filtrate and a concentrate o...  
WO/2017/031211A1
This disclosure concerns compositions and methods for targeting peptides, polypeptides, and proteins to plastids of plastid-containing cells. In some embodiments, the disclosure concerns chloroplast transit peptides that may direct a pol...  
WO/2017/030457A1
The invention relates to the field of protecting plants against pests, and more particularly to a method of protecting plants against pests, which can be used for industrial and scientific purposes, in agriculture, horticulture and fo...  
WO/2017/028151A1
The present invention provides a composite microbial live bacterial agent for effectively degrading aniline in waste water, and a preparation method and application thereof. The composite microbial live bacterial agent comprises Acinetob...  
WO/2017/029733A1
In this biological reaction device and this biological reaction method which uses said biological reaction device, micro-nanobubbles (MNB) are included in a biological culture solution extracted from a culture tank, a filter is used to s...  
WO/2017/025586A1
The present disclosure relates to compositions and methods useful for the production of heterologous proteins in filamentous fungal cells.  
WO/2017/027568A1
The present invention generally relates to compositions and methods for delivering a vaccine. The compositions and methods disclosed herein are particularly useful in making bacterial and viral vaccines.  
WO/2017/025648A1
A recombinant host capable of producing a steviol glycoside which overexpresses a polypeptide which mediates steviol glycoside transport and which polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 29 or an amino acid ...  

Matches 351 - 400 out of 97,368